Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE005898 |
YEM_ID: | YEM-98 |
YNS_ID: | YNS-113 |
XU_ID: | XU-75 |
ID: | TCMBANKHE005898/YNS-113/YEM-98/XU-75 |
植物拉丁名: |
|
功能与主治: | 祛风除湿，舒经通络，消肿止痛。用于风寒湿痹，关节肿痛，跌倒损伤，红斑狼疮，皮痹瘙痒骨痨骨疽，睾丸结核|To dispel wind and eliminate damp, quicken blood and stanch bleeding, soothe sinews and joint bones, resolve toxin and kill worms./Rheumatic arthritis, wind-damp impediment pain, hemiplegia, mounting qi , dysmenorrhea, profuse menstruation, postpartum abdominal pain, incessant bleeding, acute infectious hepatitis, chronic nephritis, erythematous lupus, fracture, medullitis, bone tuberculosis, epididymis tubercle, sore toxin, psoriasis, neurodermatitis. |
药用植物名: | 昆明山海棠 |
药名: | 火把花根|昆明山海棠 |
来源: | 云南药材标准：第二册|云南民族药物志：第一卷|云南省保山市隆阳区瓦房乡 |
药用部位: | root|干燥根|根 |
使用民族: | 哈尼族/拉祜族/傈僳族/彝族 |
科: | 卫矛科 |
属: | 雷公藤属 |
KUMST_ID1: | KMUST-BS-0079 |
KUMST_ID2: | KMUST-20201015010-1，-2 |
TCM_ID_id: | 3550 |
 Hutch.|Tripterygium hypoglaucum (Lévl. )Lévl.ex ex Hutch.1.jpg)
 Hutch.|Tripterygium hypoglaucum (Lévl. )Lévl.ex ex Hutch.2.jpg)
 Hutch.|Tripterygium hypoglaucum (Lévl. )Lévl.ex ex Hutch.3.jpg)
 Hutch.|Tripterygium hypoglaucum (Lévl. )Lévl.ex ex Hutch.4.jpg)
 Hutch.|Tripterygium hypoglaucum (Lévl. )Lévl.ex ex Hutch.5.jpg)
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN006825 | triptotriterpenicacid a' | CC1(CCC2(CC(C3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)O)C)C)C2C1)C)O)C(=O)O)C | |||
| TCMBANKIN012468 | Tripdiotolnide | tripdiotolnide | 360.44 | C.CC(C)C12C(O1)C(C3=C(C2O)C(=O)CC4C3(CCC5=C4COC5=O)C)O | |
| TCMBANKIN012894 | TRIPTONOLIDE | triptonolide; 6-hydroxy-9b-methyl-7-propan-2-yl-3b,4,10,11-tetrahydro-3H-naphtho[2,1-e][2]benzofuran-1,5-dione; AC1NT199 | C20H22O4 | 326.4 g/mol | CC(C)C1=C(C2=C(C=C1)C3(CCC4=C(C3CC2=O)COC4=O)C)O |
| TCMBANKIN013084 | 3β-acetoxyolean-12-en-28-oicacid | 3β-acetoxyolean-12-en-28-oic acid | C32H50O4 | ||
| TCMBANKIN016599 | Wilsonine | wilsonine | C20H25NO4 | 343.4 g/mol | COC1CC23C4=CC(=C(C=C4CCCN2CC5C3(O5)C=C1)OC)OC |
| TCMBANKIN024521 | triptofordin a | CC1(C2CC(C3(C(CCC(C3(C2)O1)(C)O)OC(=O)C4=CC=CC=C4)C)OC(=O)C=CC5=CC=CC=C5)C | |||
| TCMBANKIN024547 | hypoepistephanine | C36H36N2O6 | 592.7 g/mol | CN1CCC2=CC(=C3C=C2C1CC4=CC(=C(C=C4)O)OC5=CC=C(CC6=NCCC7=CC(=C(C(=C76)O3)OC)OC)C=C5)OC | |
| TCMBANKIN025619 | (+)-Catechin-5-O-glucoside | (2S,3R,4S,5S,6R)-2-[[(2R,3S)-2-(3,4-dihydroxyphenyl)-3,7-dihydroxy-5-chromanyl]oxy]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol; (2S,3R,4S,5S,6R)-2-[(2R,3S)-2-(3,4-dihydroxyphenyl)-3,7-dihydroxy-chroman-5-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol; (2S,3R,4S,5S,6R)-2-[(2R,3S)-2-(3,4-dihydroxyphenyl)-3,7-dihydroxychroman-5-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol; (+)-catechin-5-o-glucoside; (2S,3R,4S,5S,6R)-2-[(2R,3R)-2-(3,4-dihydroxyphenyl)-3,7-dihydroxy-chroman-5-yl]oxy-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol; (2S,3R,4S,5S,6R)-2-[(2R,3S)-2-(3,4-dihydroxyphenyl)-3,7-dihydroxy-chroman-5-yl]oxy-6-methylol-tetrahydropyran-3,4,5-triol; (2S,3R,4S,5S,6R)-2-[(2R,3S)-2-(3,4-dihydroxyphenyl)-3,7-dihydroxy-chroman-5-yl]oxy-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol; (?)-Epicatechin-5-O-beta-D-glucopyranoside | C21H24O11 | 452.4 g/mol | C1C(C(OC2=C1C(=CC(=C2)O)OC3C(C(C(C(O3)CO)O)O)O)C4=CC(=C(C=C4)O)O)O |
| TCMBANKIN030123 | 3-oxo-olean-12-en-29-oicacid | C30H46O3 | 454.7 g/mol | CC1(C2CCC3(C(C2(CCC1=O)C)CC=C4C3(CCC5(C4CC(CC5)(C)C(=O)O)C)C)C)C | |
| TCMBANKIN030937 | wilforgine | CHEMBL503640 | C41H47NO19 | 857.8 g/mol | CC1CCC2=C(C=CC=N2)C(=O)OCC3(C4C(C(C5(C(C(C(C(C5(C4OC(=O)C)O3)(C)O)OC1=O)OC(=O)C6=COC=C6)OC(=O)C)COC(=O)C)OC(=O)C)OC(=O)C)C |
| TCMBANKIN035934 | Triptonoditerpenic acid | 2-Phenanthrenecarboxylic acid, 3,4,4a,9,10,10a-hexahydro-8-hydroxy-6-methoxy-1,4a-dimethyl-7-(1-methylethyl)-; AC1L30OA; 8-HYDROXY-7-ISOPROPYL-6-METHOXY-1,4A-DIMETHYL-4,9,10,10A-TETRAHYDRO-3H-PHENANTHRENE-2-CARBOXYLIC ACID; triptonoditerpenicacid; 8-hydroxy-6-methoxy-1,4a-dimethyl-7-propan-2-yl-4,9,10,10a-tetrahydro-3H-phenanthrene-2-carboxylic acid; 139953-20-1; triptonoditerpenic acid | C21H28O4 | 344.44 | CC1=C(CCC2(C1CCC3=C(C(=C(C=C32)OC)C(C)C)O)C)C(=O)O |
| TCMBANKIN036830 | triptonide | Triptolide, 14-deoxy-14-oxo-; AC-20331; 38647-11-9; KBio1_001608; Spectrum_001724; AKOS025401513; KBioSS_002204; BC216334; NSC165677; NCI60_001273; DivK1c_006664; Triptonide; KBio2_004772; SPBio_000614; Spectrum2_000477; KBio2_007340; Spectrum5_001806; ZINC100038923; SpecPlus_000568; KBio2_002204 | C20H22O6 | 358.385 | C12=C(C([H])([H])C([H])([H])[C@]3(C([H])([H])[H])[C@@]1([H])C([H])([H])[C@@]([H])(O4)[C@]45[C@]36[C@]([H])(O6)[C@]7([H])[C@@](C([H])(C([H])([H])[H])C([H])([H])[H])(O7)C5=O)C(=O)OC2([H])[H] |
| TCMBANKIN036848 | triptolide | PG 490; CT0223; Bio2_000315; AKOS015895128; KBio2_005451; BSPBio_001595; NCGC00163411-02; Triptolide; BCPP000033; Trisoxireno[4b,5:6,7:8a,9]phenanthro[1,2-c]furan-(3H)-one, 3b,4,4a,6,6a,7a,7b,8b,9,10-decahydro-6-hydroxy-8b-methyl-6a-(1-methylethyl)-, [3bR-(3b.alpha.,4a.alpha.,5aS*,6.beta.,6a.beta.,7a.beta.,7b.alpha.,8aS*,8b.beta.)]-; KBio3_000629; N1733; CHEBI:94966; SCHEMBL10028421; Trisoxireno(4b,5:6,7:8a,9)phenanthro(1,2-c)furan-1(3H)-one, 3b,4,4a,6,6a,7a,7b,8b,9,10-decahydro-6-hydroxy-8b-methyl-6a-(1-methylethyl)-, (3bS,4aS,5aS,6R,6aR,7aS,7bS,8aS,8bS)-; AC-6084; IDI1_034065; NCGC00163411-01; NSC163062; KBio2_002883; NSC 163062; Bio2_000795; Triptolid; HY-32735; BRD-A13122391-001-01-9; SMR000466307; MLS000759410; Triptolide (9CI); C09204; Triptolide, <i>Tripterygium wilfordii; PG-490; ST51052768; KBio2_000315; Trisoxireno[4b,5:6,7:8a,9]phenanthro[1,2-c]furan-1(3H)-one, 3b,4,4a,6,6a,7a,7b,8b,9,10-decahydro-6-hydroxy-8b-methyl-6a-(1-methylethyl)-, [3bR-(3b.alpha.,4a.alpha.,5aS*,6.beta.,6a.beta.,7a.beta.,7b.alpha.,8aS*,8b.beta.)]-; CS-0286; KBio3_000630; Triptolide, from Tripterygium wilfordii, >=98% (HPLC), solid; 38748-32-2; PG490; SMP1_000110; KBioGR_000315; TPL; NCI60_001223; KBioSS_000315 | C20H24O6 | 360.4 | CC(C)C12C(O1)C3C4(O3)C5(CCC6=C(C5CC7C4(C2O)O7)COC6=O)C |
| TCMBANKIN038704 | procyanidin c | C21H12MnN2O6S | [H+].C1=CC=C2C(=C1)C=CC(=C2S(=O)(=O)[O-])N=NC3=C(C(=CC4=CC=CC=C43)C(=O)[O-])[O-].[Mn+2] | ||
| TCMBANKIN038768 | epigallocatechin-(4bata-8)-epicatechin-3-o-gallate ester | C37H30O17 | C1C(C(OC2=C1C(=CC(=C2C3C(C(OC4=CC(=CC(=C34)O)O)C5=CC(=C(C(=C5)O)O)O)O)O)O)C6=CC(=C(C=C6)O)O)OC(=O)C7=CC(=C(C(=C7)O)O)O | ||
| TCMBANKIN039749 | Hyponine D | 930.9 g/mol | |||
| TCMBANKIN042204 | triptotin | triptotin | C30H48O4 | 473 | [C@@]12([H])[C@@]3([C@@]([H])(O3)C([H])([H])[C@@]([H])([C@@](C([H])([H])[H])(C([H])([H])C([H])([H])[C@@](C([H])([H])[H])(C([H])([H])C([H])([H])[C@@](C([H])([H])[H])(C(O[H])=O)C4([H])[H])[C@]45[H])[C@@ ]5(C([H])([H])[H])C([H])([H])C6([H])[H])[C@]16C([H])([H])[H])C(C([H])([H])[H])(C([H])([H])[H])[C@@]([H])(O[H])C([H])([H])C2([H])[H] |
| TCMBANKIN043101 | Tripdiolide | AKOS025402191; tripdiolide; AC-6083 | C20H24O7 | 376.4 | CC(C)C12C(O1)C3C4(O3)C5(CC(C6=C(C5CC7C4(C2O)O7)COC6=O)O)C |
| TCMBANKIN044193 | hyponine e | C45H48N2O19 | 920.9 g/mol | CC1C(C(=O)OC2C(C(C3(C(C(C4C(C3(C2(C)O)OC4(COC(=O)C5=C1N=CC=C5)C)OC(=O)C6=CC=CO6)OC(=O)C7=CN=CC=C7)OC(=O)C)COC(=O)C)OC(=O)C)OC(=O)C)C | |
| TCMBANKIN046082 | Hypoglaunine | 873.8 g/mol | |||
| TCMBANKIN048483 | (+)-gallocatechin-hexacetate | [(2R,3S)-5,7-diacetyloxy-2-(3,4,5-triacetyloxyphenyl)-3,4-dihydro-2H-chromen-3-yl] acetate; AC1NSVMJ | C27H26O13 | CC(=O)OC1CC2=C(C=C(C=C2OC1C3=CC(=C(C(=C3)OC(=O)C)OC(=O)C)OC(=O)C)OC(=O)C)OC(=O)C | |
| TCMBANKIN049589 | hyponine f | C41H47NO19 | 857.8 g/mol | CC1C(C(=O)OC2C(C(C3(C(C(C4C(C3(C2(C)O)OC4(COC(=O)C5=C1N=CC=C5)C)OC(=O)C)OC(=O)C)OC(=O)C)COC(=O)C)OC(=O)C)OC(=O)C6=CC=CO6)C | |
| TCMBANKIN058510 | gallocatechin-(4α→8)epicatechin | gallocatechin-(4alpha-8)epicatechin | C30H26O13 | C1C(C(OC2=C1C(=CC(=C2C3C(C(OC4=CC(=CC(=C34)O)O)C5=CC(=C(C(=C5)O)O)O)O)O)O)C6=CC(=C(C=C6)O)O)O | |
| TCMBANKIN058518 | epigallocatechin | Spectrum5_000889; (2S,3R)-2-(3,4,5-Trihydroxyphenyl)-chroman-3,5,7-triol; 08108_FLUKA; KBio2_003854; KBioSS_001286; epi-Gallocatechin; (−)-Epigallocatechin; SPBio_000885; Epigallocatechol; (2S,3S)-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol; AIDS-001348; Spectrum_000806; NCI60_026204; BCBcMAP01_000207; (2S,3S)-(+)-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol; MCULE-9338438267; CCRIS 5441; CHEBI:42255; Spectrum4_000950; 136892-45-0; (2R,3R)-2-(3,4,5-trihydroxyphenyl)chroman-3,5,7-triol; (3,3',4',5,5',7-Hexahydroxyflavan); (−)-cis-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol; SCHEMBL1972938; (+)-epigallocatechin; AIDS001348; KBio3_001136; SDCCGMLS-0066479.P001; EGC; 1-epi-3',4',5,5',7-Pentahydroxy-3-Flavan; NSC674039; 2H-1-Benzopyran-3,5,7-triol, 3,4-dihydro-2-(3,4,5-trihydroxyphenyl)-, (2R-cis)- (9CI); 970-74-1; E3768_SIAL; EPIGALLOCATECHIN; C12136; 2H-1-Benzopyran-3,5,7-triol, 3,4-dihydro-2-(3,4,5-trihydroxyphenyl)-, (2R-cis)-; KBio2_006422; Antiscurvy factor C2; NCGC00180795-01; SpecPlus_000269; Factor C2 (antiscurvy); (-)cis-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3,5,7-triol; (-)-3,3',4',5,5',7-Flavanhexol; 98032-84-9; l-Epigallocatechol; MolPort-001-740-311; 3,3',4',5,5',7-Flavanhexol; BSPBio_001636; (-)-Epigallocatechol; (2S,3S)-2-(3,4,5-Trihydroxy-phenyl)-chroman-3,5,7-triol; (-)-Epigallocatechin; (2R,3R)-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol; 3BC1BF1C-D95B-4EB2-943E-C1F59C7501A0; KBio1_001309; (2S,3S)-epigallocatechin; KBioGR_001540; SPECTRUM205113; ZINC3870339; CHEBI:71227; (2S,3S)-flavan-3,3',4',5,5',7-hexol; CHEMBL130415; (+)-epi-gallocatechin; NP-000358; Spectrum3_000248; (−)-cis-3,3′,4′,5,5′,7-Hexahydroxyflavane; 2-(3,4,5-TRIHYDROXY-PHENYL)-CHROMAN-3,5,7-TRIOL; (+)-cis-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol; Antiscurvy factor C(sub 2); 2545-09-7; ACon1_000192; SMP1_000114; KBio2_001286; L-Epigallocatechin; DivK1c_006365; (2S,3S)-2-(3,4,5-TRIHYDROXYPHENYL)-3,4-DIHYDRO-2H-1-BENZOPYRAN-3,5,7-TRIOL; Spectrum2_000703; (+)-cis-3,3',4',5,5',7-hexahydroxyflavane; BDBM50135171; (2S,3S)-flavan-3,5,7,3',4',5'-hexol;l-epigallocatechin | C15H14O7 | 306.27 | C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C(=C3)O)O)O)O |
| TCMBANKIN059044 | Wilfotrine | wilfotrine | C41H47NO20 | 873.89 | CC(=O)OCC12C(C(C3C(C14C(C(C(C2OC(=O)C)OC(=O)C5=COC=C5)OC(=O)C(CCC6=C(C=CC=N6)C(=O)OCC3(O4)C)(C)O)(C)O)OC(=O)C)OC(=O)C)OC(=O)C |
| TCMBANKIN059168 | Tryptophenolide | KBio1_001606; KBio2_007338; KBio3_002756; Spectrum2_001618; KBio2_004770; KBio2_002202; Phenanthro(1,2-c)furan-1(3H)-one, 3b,4,5,9b,10,11-hexahydro-6-hydroxy-9b-methyl-7-(1-methylethyl)-, (3bR-trans)-; BSPBio_003528; SDCCGMLS-0066775.P001; hypolide; (3bR,9bS)-6-hydroxy-9b-methyl-7-propan-2-yl-3,3b,4,5,10,11-hexahydronaphtho[4,3-g][2]benzoxol-1-one; Spectrum4_001660; Spectrum5_000539; SPECTRUM1504005; DivK1c_006662; SPBio_001655; Triptophenolide; (3bR,9bS)-6-hydroxy-7-isopropyl-9b-methyl-3,3b,4,5,10,11-hexahydronaphtho[3,4-e]isobenzofuran-1-one; KBioGR_002159; Spectrum_001722; Spectrum3_001928; 74285-86-2; SpecPlus_000566; KBioSS_002202 | C20H24O3 | 312.4 g/mol | CC(C)C1=C(C2=C(C=C1)C3(CCC4=C(C3CC2)COC4=O)C)O |
| TCMBANKIN059539 | abrusgenicacid | C30H48O4 | 472.7 g/mol | CC1(C2CCC3(C(C2(CCC1O)C)CC=C4C3(CCC5(C4CC(CC5O)(C)C(=O)O)C)C)C)C | |
| TCMBANKIN059689 | tripterine | C29H38O4 | 450.61 | CC1=C(C(=O)C=C2C1=CC=C3C2(CCC4(C3(CCC5(C4CC(CC5)(C)C(=O)O)C)C)C)C)O | |
| TCMBANKIN059758 | triptinin a | C21H28O3 | 328.45 g/mol | CC1=C(CCC2(C1CCC3=C2C=CC(=C3OC)C(C)C)C)C(=O)O | |
| TCMBANKIN060101 | Triptolidenol | C20H24O7 | 376.4 | CC12CCC3=C(C1CC4C5(C26C(O6)C7C(C5O)(O7)C(C)(C)O)O4)COC3=O | |
| TCMBANKIN060132 | Hypodiolide A | C20H30O3 | 318.45 | CC12CCCC3(C1CCC45C3CCC(C4)C(C5)(C)O)COC2=O | |
| TCMBANKIN060304 | regelin | C31H48O4 | 484.7 g/mol | CC1C(CC(C2(C1C3=CCC4C5(CCC(=O)C(C5CCC4(C3(CC2)C)C)(C)C)C)C)O)C(=O)OC |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab